Rheumatology

Damaged tissue in older mice and human tissue samples regrew using a ‘gerozyme inhibitor’

What an U.S. FDA-approved device reveals about the role of the nervous system.

An Ontario study examined the extent to which knee osteoarthritis is often overlooked in Type 2 diabetes appointments.

Study from the Canadian Arthritis Patient Alliance highlights systemic challenges impacting Canadians with arthritis.

Pearls you can use in your practice right now.

Canadian Rheumatology Association advocates for greater pediatric access to JAK inhibitors, which can be given orally rather than subcutaneously or intravenously. 

New research is raising the prospect of treatments that might do more than tamp down symptoms.

Obesity Canada’s 2025 clinical practice guideline update on pharmacotherapy for obesity management includes recommendations for obesity management in adults with specific co-morbidities.